FDA Issues Draft Guidance on Developing Weight Loss Drugs

Seeking Alpha00:53

RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $324

Futu NewsJan 7 22:35 · Ratings

RBC Trims Price Target on Amgen to $324 From $330, Keeps Outperform Rating

MT NewswiresJan 7 20:47 · Ratings

FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development

Seeking AlphaJan 7 01:52

Amgen (NASDAQ:AMGN) Is Paying Out A Larger Dividend Than Last Year

Yahoo FinanceJan 6 20:51

Express News | Amgen UK: Imdylltra Granted Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in UK

BreakingsJan 6 17:28